Bayer Crop Sci.

The corn seed business was the primary detractor this quarter, with sales plummeting 68% in Q2. Management attributed this to a shift in farmer preference toward oilseeds, particularly soybeans, which offered better returns on investment. This resulted in lower acreages in West and Central India, leading to high sales returns and an unfavorable portfolio mix that severely impacted margins.

Gross margins compressed from 22% to 16% YoY in Q2. This was partly due to a deliberate strategy to lower prices on key brands like Solomon to attract a new segment of smallholder farmers and compete with generics. While this drove a 30% growth in Solomon sales, it contributed to the overall margin squeeze alongside rising raw material and logistics costs.

The Crop Protection segment provided a necessary buffer, growing 10% in H1. This growth was driven by strong volumes and successful price increases in the Roundup (Glyphosate) portfolio. The top five brands—Dekalb, Nativo, Laudis, Solomon, and Roundup—now account for 42% of total H1 revenue, highlighting the company's reliance on a core set of high-performing products.

The balance sheet showed signs of stress with inventory increasing by ₹3 billion and trade receivables rising by ₹1.3 billion. Cash flow from operations saw a significant reduction of ₹6 billion compared to the previous year. Management attributed the receivable spike to a 'base effect' from the COVID period when collections were exceptionally high, but the current DSO remains a point of analyst concern.

Management is banking on the Q3 launch of Vayego, a new insecticide, to drive future growth. They are also scaling digital initiatives like 'Sahbhaagi' (extension workers) and 'Better Life Farming' centers to deepen connect with smallholders. Despite short-term headwinds, they remain committed to a global goal of reaching 100 million smallholder farmers, viewing the current margin sacrifice as an investment in long-term market share.